Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
帕博利珠单抗联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌患者：一项开放标签、多臂、非随机、多中心 II 期试验
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(21)00136-4
Sacco, Assuntina G; Chen, Ruifeng; Worden, Francis P; Wong, Deborah J L; Adkins, Douglas; Swiecicki, Paul; Chai-Ho, Wanxing; Oppelt, Peter; Ghosh, Debanjali; Bykowski, Julie; Molinolo, Alfredo; Pittman, Emily; Estrada, M Valeria; Gold, Kathryn; Daniels, Gregory; Lippman, Scott M; Natsuhara, Amanda; Messer, Karen; Cohen, Ezra E W
